Primary information |
---|
ID | antitb_1228, |
Name | 23993672 |
N-Terminal modification | High Activity Binding Peptides (HABPs) |
C-Terminal Modification | TGMAALEQYLGSGHAVIVSI |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 20 |
Source | L |
Species | Protein Derived |
Strain | From Rv1268c protein |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Inhibition Concentration | In vitro |
Sequence | 2013 |
Cytotoxicity | alveolar epithelial cells A549 (ATCC No. CCL-185) |
In vivo Model | Inhibited mycobacterial entry by up to 65%. |
Lethal Dose | NA |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Inhibit mycobacterial entry into cells |
Other activities | NA |
PMID | None |
Year of Publication | None |
Tertiary Structure (Technique) | Not Predicted), |